Antiplatelet Trialists’ Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320–332.
Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC: A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA 1992;268:240–248.
Arevalo JA, Washington AE: Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. JAMA 1988;259:365–369.
Armitage P, Berry G: Statistical Methods in Medical Research, 2nd ed. Oxford, Blackwell Scientific Publications, 1987; pp 409–410.
Armstrong BK: Oestrogen therapy after the menopause—boon or bane? Med J Aust 1988;148:213–214.
Bailar J: The practice of meta-analysis. J Clin Epidemiol 1995;48:149–157.
Bailey KR: Inter-study differences: how should they influence the interpretation and analysis of results? Stat Med 1987;6:351–358.
Bayarri MJ: Comment on “Selection models and the file drawer problem.” Stat Science 1988;3:128–131.
Beck JR, Kassirer JP, Pauker SG: A convenient approximation of life expectancy (the “DEALE”): I. Validation of the method. Am J Med 1982a;73:883–888.
Beck JR, Pauker SG: The Markov process in medical prognosis. Med Decis Making 1983;3:419–458.
Beck JR, Pauker SG, Gottlieb JE, Klein K, Kassirer JP: A convenient approximation of life expectancy (the “DEALE”): II. Use in medical decision-making. Am J Med 1982b;73:889–897.
Begg CB: Publication bias. In: The Handbook of Research Synthesis, Cooper H, Hedges LV (eds). New York, Russell Sage Foundation, 1994; pp 399–409.
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF: Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996;276:637–639.
(p.284) Begg CB, Berlin JA: Publication bias: a problem in interpreting medical data. J Royal Stat Soc A 1988;151:419–463.
Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL: Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 1997;127:855–865.
Berlin JA: Does blinding of readers affect the results of meta-analyses. Lancet 350;1997:185–186.
Berlin JA, Longnecker MP, Greenland S: Meta-analysis of epidemiologic dose-response data. Epidemiology 1993;218–228.
Berlin JA, Laird NM, Sacks HS, Chalmers TC: A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989;8:141–151.
Bernal-Delgado E, Latour-Perez J, Pradas-Arnal F, Gomez-Lopez L: The association between vasectomy and prostate cancer: a systematic review of the literature. Fertil Steril 1998;70:191–200.
Bero L, Rennie D: The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. JAMA 1995;274:1935–1938.
Binkin NJ, Koplan JD: The high cost and low efficacy of weekly viral cultures for pregnant women with recurrent genital herpes: a reappraisal. Med Decis Making 1989;9:225–230.
Borzak S, Ridker PM: Discordance between meta-analyses and large-scale randomized, controlled trials. Ann Intern Med 1995;123:873–877.
Boyle MH, Torrance GW: Developing multiattribute health indexes. Med Care 1984;22:1045–1057.
Bulpitt CJ: Meta-analysis. Lancet 1988;2:93–94.
Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Sutchindran CM, Tyroler HA, Rifkind BM: Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 1987;75:1102–1109.
Bushman BJ: Vote-counting procedures in meta-analysis. In: The Handbook of Research Synthesis, Cooper H, Hedges LV (eds). New York, Russell Sage Foundation, pp 193–213.
Callahan ML, Wears RL, Weber EJ, Barton C, Young G: Positive-outcome bias and other limitations in the outcome of research abstracts submitted to a scientific meeting. JAMA 1998;280:254–257.
Cappelleri JC, Ioannidis JPA, Schmid CH, deFerranti SD, Aubert M, Chalmers TC, Lau J: Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA 1996;276:1332–1338.
Centers for Disease Control: Measles—United States, 1989 and first 20 weeks 1990. MMWR 1990;39:353–355, 361–363.
Chalmers I, Adams M, Dickersin K, Hetherington J, Tarnow-Mordi W, Meinert C, Tonascia S, Chalmers TC: A cohort study of summary reports of controlled trials. JAMA 1990;263:1401–1405.
Chalmers TC, Block JB, Lee S: Controlled studies in clinical cancer research. N Engl J Med 1972;287:75–78.
Chalmers TC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A: A method for assessing the quality of a randomized control trial. Control Clin Trials 1981;2:31–49.
Chalmers TC, Berrier J, Sacks HS, Levin H, Reitmen D, Nagalingam R: Meta-analysis of clinical trials as a scientific discipline: II. Replicate variability and comparison of studies that agree and disagree. Stat Med 1987b;6:733–744.
(p.285) Chalmers TC, Levin H, Sacks HS, Reitmen D, Berrier J, Nagalingam R: Meta-analysis of clinical trials as a scientific discipline: I. Control of bias and comparison with large cooperative trials. Stat Med 1987a;6:315–325.
Cochran WG: Problems arising in the analysis of a series of similar experiments. J Royal Stat Soc B 1937;4:102–118.
Cochran WG: The combination of estimates from different experiments. Biometrics 1954;10:101–129.
Colditz GA, Miller JN, Mosteller F: How study design affects outcomes in comparisons of therapy: I. Medical. Stat Med 1989;8:441–454.
Colditz GA, Burdick E, Mosteller F: Heterogeneity in meta-analysis of data from epidemiologic studies: a commentary. Am J Epidemiol 1995;142:371–382.
Collaborative Group on Hormonal Factors in Breast Cancer: Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiologic studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047–1059.
Collins R, Yusuf S, Peto R: Overview of randomized trials of diuretics in pregnancy. Br Med J 1985;290:17–23.
Cook DJ, Guyatt GH, Ryan G, Clifton J, Buckingham L, Willan A, McIlroy W, Oxman AD: Should unpublished data be included in meta-analyses? Current convictions and controversies. JAMA 1993;269:2749–2753.
Cook DJ, Sackett DL, Spitzer WO: Methodologic guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol 1995;48:167–171.
Critchfield GC, Willard KE: Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making 1986;6:85–92.
Danese MD, Powe NR, Sawin CT, Ladenson PW: Screening for mild thryoid failure at the periodic health examination: a decision and cost-effectiveness analysis. JAMA 1996;276:285–292.
De Bruin AF, De Witte LP, Stevens F, Diedericks JP: Sickness Impact Profile: the state of the art of a generic functional status measure. Soc Sci Med 1992:35:1003–1014.*
deBellefeuille C, Morrison C, Tannock I: The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol 1992;3:187–191.
Demets DL: Methods for combining randomized clinical trials: strengths and limitations. Stat Med 1987;6:341–348.
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986;7:177–188.
Detsky AS, Naglie IG: A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990;113:147–154.
Detsky AS, Naylor CD, O’Rourke K, McGeer AJ, L’Abbe KA: Incorporating variations in the quality of individual randomized trials into meta-analysis. J Clin Epidemiol 1992;45:255–265.
Devine EC, Cook TD: A meta-analytic analysis of effects of psychoeducational interventions on length of postsurgical hospital stay. Nursing Res 1983;32:267–274.
Dickersin K, Scherer R, Lefebvre C: Identifying relevant studies for systematic reviews. BMJ 1994;309:1286–1291.
Dickersin K, Berlin JA: Meta-analysis: state-of-the-science. Epidemiol Rev 1992;14:154–176.
(p.286) Dickersin K, Hewitt P, Mutch L, Chalmers I, Chalmers TC: Comparison of MEDLINE searching with a perinatal trials database. Control Clin Trials 1985;6:306–317.
Dickersin K, Min Y-I, Meinert CL: Factors influencing publication of research results: follow-up of applications submitted to two institutional review boards. JAMA 1992;267:374–378.
Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ: Probabilistic sensitivity analysis using Monte Carlo simulation: a practical approach. Med Decis Making 1985;5:157–177.
Doubilet P, Weinstein MC, McNeil BJ: Use and misuse of the term “cost effective” in medicine. N Engl J Med 1986;314:253–256.
Drummond MF: Resource allocation decisions in health care: a role for quality of life assessments? J Chron Dis 1987;40:605–616.
Drummond MF, O’Brien B, Stoddart GL, Torrance GW: Methods of Economic Evaluation of Health Care Programmes. 2nd ed. Oxford, Oxford University Press, 1997.
Dudley HAF: Surgical research: master or servant? Am J Surg 1978;135:458–460.
Dupont WD, Page DL: Menopausal estrogen replacement therapy and breast cancer. Arch Intern Med 1991;151:67–72.
Early Breast Cancer Trialists’ Collaborative Group: Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 1988;319:1681–1692.
Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in research. Lancet 1991;337:867–872.
Eddy DM: The confidence profile method: a Bayesian method for assessing health technologies. Oper Res 1989;37:210–228.
Eddy DM, Hasselblad V, Shachter R: A Bayesian method for synthesizing evidence: the confidence profile method. Int J Tech Assess Health Care 1990a;6:31–55.
Eddy DM, Hasselblad V, Shachter R: An introduction to a Bayesian method for meta-analysis: the confidence profile method. Med Decis Making 1990b;10:15–23.
Egger M, Zellweger-Zahner T, Schneider M, Junker C, Lengeler C, Antes G: Language bias in randomised controlled trials published in English and German. Lancet 1997;350:326–329.**
Elbourne D, Oakley A, Chalmers I: Social and psychological support during pregnancy. In: Effective Care in Pregnancy and Childbirth, vol 1, Pregnancy. Chalmers I, Enkin M, Keirse MJN (eds). Oxford, Oxford University Press, 1989; pp 221–236.
Essink-Bot ML, Stouthard ME, Bonsel GJ: Generalizability of valuations on health states collected with the EuroQol questionniare. Heath Econ 1993;2:237–246.*
EuroQol Group: EuroQol: a new facility for measurement of health-related quality of life. Health Policy 1990;16:199–208.
Eysenck HJ: An exercise in mega-silliness. Am Psychol 1978;33:517.
Fineberg HV, Scadden D, Goldman: Care of patients with a low probability of acute myocardial infarction: cost effectiveness of alternatives to coronary-care-unit admissions. N Engl J Med 1984;310:1301–1307.
Finkler SA: The distinction between cost and charges. Ann Intern Med 1982;96:102–109.
Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994;271:1940–1947.
Fisher RA: Statistical Methods for Research Workers, 4th ed. London, Oliver and Boyd, 1932.
Fleiss JL: Statistical Methods for Rates and Proportions. 2nd ed. New York, J Wiley, 1981, pp 161–165.
Fleiss JL: The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121–145.
Fleiss JL, Gross AJ: Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: a critique. J Clin Epidemiol 1991;44:127–139.
(p.287) Fleming C, Wasson JH, Albertsen PC, Barry MJ, Wennberg JE for the Prostate Patient Outcomes Research Team: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 1993;2650–2658.
Friedenreich CM: Methods for pooled analyses of epidemiologic studies. Epidemiology 1993;4:295–302.
Froberg DG, Kane RL: Methodology for measuring health-state preferences: IV. Progress and a research agenda. J Clin Epidemiol 1989d;42:675–685.
Froberg DG, Kane RL: Methodology for measuring health-state preferences: III. Population and context effects. J Clin Epidemiol 1989c;42:485–592.
Froberg DG, Kane RL: Methodology for measuring health-state preferences: II. Scaling methods. J Clin Epidemiol 1989b;42:459–471.
Froberg DG, Kane RL: Methodology for measuring health-state preferences: I. Measurement strategies. J Clin Epidemiol 1989a;42:345–354.
Fryback DG, Lawrence WF, Martin PA, Klein R, Klein BEK: Predicting quality of well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study. Med Decis Making 1997;17:1–9.
Gage BF, Cardinalli AB, Albers GW, Owens DK: Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. JAMA 1995;274:1839–1845.
Garfinkel L, Auerbach O, Joubert L: Involuntary smoking and lung cancer: a case-control study. J Natl Cancer Inst 1985;75:463–469.
Genduso LA, Kotsanos JG: Review of health economic guidelines in the form of regulations, principles, policies, and positions. Drug Information J 1996;30:1003–1016.
GISSI (Gruppo Italiano per lo Studio Della Streptochiasi Nell’infarto Miocardico): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397–402.
Gladen BC, Rogan WJ: On graphing rate ratios. Am J Epidemiol 1983;118:905–908.
Glass GV: Primary, secondary and meta-analysis of research. Educ Res 1976;5:3–8.
Glass GV, McGaw B, Smith ML: Meta-analysis in Social Research. Beverly Hills, Calif, Sage Publications, 1981.
Gleser LJ, Olkin I: Models for estimating the number of unpublished studies. Stat Med 1996;15:2493–2507.
Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-effectiveness in Health and Medicine. New York, Oxford University Press, 1996.
Goldman L, Loscalzo A: Fate of cardiology research originally published in abstract form. N Engl J Med 1980;303:255–259.
Goldman L, Weinstein MC, Goldman PA, Williams LW: Cost-effectiveness of HMG-Co-A reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 1991;265:1145–1151.
Grady D, Rubin S, Petitti DB, Fox C, Black D, Ettinger B, Ernster V, Cummings SR. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016–1037.
Greenland S: Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 1987;9:1-30.
Greenland S, Longnecker MP: Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301–1309.
Greenland S, Rothman KJ: Measures of effect and measures of association. In Rothman KJ and Greenland S. Modern Epidemiology. 2nd edition. Lipponcott-Raven, Philidelphia, 1998; pp.47–64.
(p.288) Greenland S, Salvan A: Bias in the one-step method for pooling study results. Stat Med 1990;9:247–252.
Greenland S, Schlesselman JJ, Criqui MH: The fallacy of employing standardized regression coefficients and correlations as measures of effect. Am J Epidemiol 1987;123:203–208.
Gregoire G, Derderian F, Le Lorier J: Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995;48:159–163.
Harris J: QALYfying the value of life. J Med Ethics 1987;13:117–123.
Hebert JR, Miller DR: Plotting and discussion of rate ratios and relative risk estimates. J Clin Epidemiol 1989;3:289–290.
Heckerling PS, Verp MS: Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis. J Clin Epidemiol 1991;44:657–670.
Hedges LV: Estimation of effect size from a series of independent experiments. Psychol Bull 1982;92:490–499.
Hedges LV: Combining independent estimators in research synthesis. Br J Math Stat Psychol 1983;36:123–131.
Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. Orlando, Florida, Academic Press, 1985.
Hedges LV, Olkin I: Vote-counting methods in research synthesis. Psychol Bull 1980;88:359–369.
Hedges LV: Estimation of effect size under nonrandom sampling: the effects of censoring studies yielding statistically insignificant mean differences. J Educ Stat 1984;9:61–85.
Henschke UK, Flehinger BJ: Decision theory in cancer therapy. Cancer 1967;20:1819–1826.
Hillner BE, Smith TJ: Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer: a decision-analysis model. N Engl J Med 1991;324:160–168.
Himel HN, Liberati A, Gelber RD, Chalmers TC: Adjuvant chemotherapy for breast cancer: a pooled estimate based on published randomized control trials. JAMA 1986;256:1148–1159.
Hunter JE, Schmidt FL, Jackson BG: Meta-Analysis: Cumulating Research Findings Across Studies. Beverly Hills, Calif, Sage Publications, 1982.
Ioannidis JPA, Lau J: Can quality of clinical trials and meta-analyses by quantified? Lancet 1998;352:590.
Ioannidis JPA: Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 1998;279:281–286.
Iyengar SI, Greenhouse JB: Selection models and the file drawer problem. Stat Science 1988;3:109–117.
Jenicek M: Meta-analysis in medicine: where we are and where we want to go. J Clin Epidemiol 1989;42:35–44.
Jenson HB, Pollock BH: The role of intravenous immunoglobulin for the prevention and treatment of neonatal sepsis. Seminars Perinatal 1998;22:50–63.
Jordan TJ, Lewit EM, Montgomery RL, Reichman LB: Isoniazid as preventive therapy in HIV-infected intravenous drug abusers: a decision analysis. JAMA 1991;265:2987–2991.
Kaplan RM, Anderson JP: A general health policy model: update and applications. Health Serv Res 1988;23:203–205.
Kaplan RM, Bush JW: Health-related quality of life measurement for evaluation research and policy analysis. Health Psychol 1982;1:61–80.
Kassirer JP: The principles of clinical decision making: an introduction to decision analysis. Yale J Biol Med 1976;49:149–164
(p.289) Kassirer JP, Angell M: The Journal’s policy on cost-effectiveness analyses. N Engl J Med 1994;331:669–670.
Kassirer JP, Pauker SG: The toss-up. N Engl J Med 1981;305:1467–1469.
Keeler EB, Cretin S: Discounting of life-saving and other non-monetary benefits. Management Science 1983;29:300-306.
Kerlikowske K, Brown JS, Grady DG: Should women with familial ovarian cancer undergo prophylactic oophorectomy. Obstet Gynecol 1992;80:700–707.
Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL: Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149–154.
Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif, Lifetime Learning, 1982.
Koren G, Graham K, Shear H, Einarson T: Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet 1989;2:1440–1444.
L’Abbe KA, Detsky AS, O’Rourke K: Meta-analysis in clinical research. Ann Intern Med 1987;107:224–233.
Laird NM, Mosteller F: Some statistical methods for combining experimental results. Int J Tech Assess Health Care 1990;6:5–30.
Lam TH, Kung IT, Wong CM, Lam WK, Kleevens JW, Saw D, Hsu D, Seneviratne S, Lam SY, Lo KK, Chan WC: Smoking, passive smoking and histologic types in lung cancer in Hong Kong Chinese women. Br J Cancer 1987;6:673–678.
Lam W, Sze PC, Sacks HS, Chalmers TC: Meta-analysis of randomized controlled trials of nicotine chewing gum. Lancet 1987;2:27–30.
LaPuma J, Lawlor EF: Quality-adjusted life-years: ethical implications for physicians and policymakers. JAMA 1990;263:2917–2921.
Lau J, Ioannidis PA, Schmid CH: Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820–827.
Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC: Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med 1992;327:248–254.
Lau J, Schmid CH, Chalmers TC: Cumulative meta-analysis of clinical trials builds evidence for exemplary meta-analysis. J Clin Epidemiol 1995;48:45–57.
Lau J, Ioannidis JPA, Schmid CH: Summing up evidence: one answer is not always enough. Lancet 1998;351:123–127.
Ledley RS, Lusted LB: Reasoning foundations of medical diagnosis: symbolic logic, probability, and value theory aid our understanding of how physicians reason. Science 1959;130:9–21.
LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F: Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536–542.
Lieu TA, Gurley JR, Lundstrom RJ, Ray GT, Fireman BH, Weinstein MC, Parmley WW: Projected cost-effectiveness of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1997;30:1741–1750.
Light RJ, Pillemer DB: Summing Up: The Science of Reviewing Research. Cambridge, Mass, Harvard University Press, 1984.
Light RJ (ed): Evaluation Studies. Review Annual, vol 8. Beverly Hills, Calif, Sage Publications, 1983.
Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: I. Reduction in incidence of coronary heart disease. JAMA 1984a;251:351–364.
Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results: II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984b;25:365–374.
(p.290) Littenberg B: Aminophylline treatment in severe, acute asthma: a meta-analysis. JAMA 1988;259:1678–1684.
Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF: The measurement of patients’ values in medicine. Med Decis Making 1982;2:449–462.
Llewellyn-Thomas H, Sutherland HJ, Tibshirani R, Ciampi A, Till JE, Boyd NF: Describing health states: methodologic issues in obtaining values for health states. Med Care 1984;22:543–552.
Longnecker MP, Berlin JA, Orza MJ, Chalmers TC: A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA 1988;260:652–656.
Lusted LB: Decision-making studies in patient management. N Engl J Med 1971;284:416–424.
Mantel N: Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. JASA 1963;58:690–700.
Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719–748.
Mantel N, Brown C, Byar DP: Tests for homogeneity of effect in an epidemiologic investigation. Am J Epidemiol 1977;106:125–129.
Mast EE, Berg JL, Hanrahan LP, Wassell JT, Davis JP: Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies. JAMA 1990;264:2529–2533.
McCormick MC, Holmes JH: Publication of research presented at the pediatric meetings: change in selection. Am J Dis Child 1985;139:122–126.
McDowell I, Newell C: Measuring Health. A Guide to Rating Scales and Questionnaires, 2nd edition. New York, Oxford University Press, 1996.
McHorney CA: Measuring and monitoring health status in elderly persons: practical and methodological issues in using the SF-36 Health Survey. Gerontologist 1996;36:571–593.
Meier P: Commentary on “Why do we need systematic overviews of randomized trials?” Stat Med 1987;6:329–331.
Meinert CL: Trials: Design, Conduct, and Analysis. Oxford, Oxford University Press, 1986.
Meranze J, Ellison N, Greenhow DE: Publications resulting from anesthesia meeting abstracts. Anesth Analg 1982;61:445–448.
Midgley JP, Matthew AG, Greenwood CM, Logan AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996;275:1590–1597.
Miller GA: The magical number seven plus or minus two: some limits on our capacity to process information. Psycho Rev 1956;63:81–97.
Miller JN, Colditz GA, Mosteller F: How study design affects outcomes in comparisons of therapy: II. Surgical. Stat Med 1989;8:455–466.
Miller MA, Sutter RW, Strebel PM, Hadler SC: Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA 1996;276:967–971.
Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, Tugwell P, Klassen TP: Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998;352:609–613.
Moher D, Fortin P, Jadad AR, Juni P, Klassen T, LeLorier J, Liberati A, Linde K, Penna A: Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996;347:363–366.
(p.291) Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S: Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin Trials 1995;16:62–73.
Morgenstern H: Uses of ecologic analysis in epidemiologic research. Am J Public Health 1982;72:1336–1344.
Morgenstern H, Greenland S: Graphing ratio measures of effect. J Clin Epidemiol 1990;6:539–542.
Nord E: Toward quality assurance in QALY calculations. Inter J Tech Assess Health Care 1993;9:37–45.
O’Brien B: Principles of economic evaluation for health care. J Rheumatol 1995;22:1399–1402.
Office of Technology Assessment (OTA). U.S. Congress. Evaluation of the Oregon Medicaid Proposal. OTA-H-531. Washington, DC, U.S. Government Printing Office, 1992.
Orwin RG: A fail-safe N for effect size in meta-analysis. J Educ Stat 1983;8:157–159.
Oster G, Epstein AM: Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. JAMA 1987a;258:2381–2387.
Oster G, Tuden RL, Colditz GA: A cost-effectiveness analysis of prophylaxis against deepvein thrombosis in major orthopedic surgery. JAMA 1987b;257:203–208.
Pauker SG, Kassirer JP: Decision analysis. N Engl J Med 1987;316:250–258.
Pearson ES: The probability integral transformation for testing goodness of fit and combining independent tests of significance. Biometrika 1938;30:134–148.
Petitti DB, Perlman JA, Sidney S: Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol 1987;70:289–293.
Peto R, Collins R, Gray R: Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 1995;48:23–40.
Peto R: Why do we need systematic overviews of randomized trials? Stat Med 1987;6:233–240.
Phillips K: The use of meta-analysis in technology assessment: a meta-analysis of the enzyme immunosorbent assay human immunodeficiency virus antibody test. J Clin Epidemiol 1991;44:925–931.
Pliskin JS, Shepard DS, Weinstein MC: Utility functions for life years and health status. Oper Res 1980;28:206–224.
Pogue J, Yusuf S: Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet 1998;351:47–52.
Poole C, Greenland S: Random-effects meta-analyses are not always conservative, in press.
Prentice RL, Thomas DB: On the epidemiology of oral contraceptives and disease. Adv Cancer Res 1986;49:285–401.
Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997;277:739–745.
Radhakrishna S: Combination of results from several 2 × 2 contingency tables. Biometrics 1965;21:86–98.
Ransohoff DF, Gracie WA, Wolfenson LB, Neuhauser D: Prophylactic cholecystectomy or expectant management for silent gallstones. Ann Intern Med 1983;99:199–204.
Rao CR: Comment on “Selection models and the file drawer problem.” Stat Science 1988;3:131–132.
Rawles J: Castigating QALYs. J Med Ethics 1989;15:143–147.
Read JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC: Preferences for health outcomes: comparison of assessment methods. Med Decis Making 1984;4:315–329.
(p.292) Rifkin RD: Classical statistical considerations in medical decision models. Med Decis Making 1983;3:197–214.
Robins J, Greenland S, Breslow NE: A general estimator for the variance of the Mantel-Haenszel odds ratio. Am J Epidemiol 1986;124:719–723.
Rosenthal R: The “file drawer problem” and tolerance for null results. Psychol Bull 1979;86:638–641.
Rosenthal R: Combining results of independent studies. Psychol Bull 1978;85:185–193.
Rosenthal R, Rubin DB: Further meta-analytic procedures for assessing cognitive gender differences. J Educ Psychol 1982;74:708–712.
Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC, for the Panel on Cost-Effectiveness in Health and Medicine: The role of cost-effectiveness analysis in health and medicine. JAMA 1996;276;1172–1177.
Sacks HS, Chalmers TC, Smith H Jr: Sensitivity and specificity of clinical trials: randomized v. historical controls. Ann Intern Med 1983;143:753–755.
Sacks HS, Berrier J, Reitman D, Ancona-Berk VA, Chalmers TC: Meta-analysis of randomized controlled trials. N Engl J Med 1987;316:450–455.
Saint S, Bent S, Vittinghoff E, Grady D: Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta-analysis. JAMA 1995;273:957–960.
Schesselman J: Risk of endometrial cancer in relation to use of combined oral contraceptives: a practitioner’s guide to meta-analysis. Hum Reprod 1997;12:1851–1863.
Schrag D, Kuntz KM, Garber JE, Weeks JC: Decision analysis—effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med 1997;336:1465–1471.
Schulman KA, Lynn LA, Glick HA, Eisenberg JM: Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus (HTV) infection. Ann Intern Med 1991;114:798–802.
Schwartz WB, Gorry GA, Kassirer JP, Essig A: Decision analysis and clinical judgment. Am J Med 1973;55:459–472.
Shapiro S: Meta-analysis/Shmeta-analysis. Am J Epidemiol 1994; 140:771–778.
Shipp M, Croughan-Minihane MS, Petitti DB, Washington AE: Estimation of the breakeven point for smoking cessation programs in pregnancy. Am J Public Health 1992;82:383–390.
Siegel JE, Weinstein MC, Russell LB, Gold MR: Recommendations for reporting cost-effectiveness analyses. JAMA 1996;276:1339–1341.
Sillero-Arenas M, Delgado-Rodriguez M, Rodriguez-Canteras R, Bueno-Cavanillas A, Galvez-Vargas R: Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet Gynecol 1992;79:286–294.
Simes JR: Treatment selection for cancer patients: application of statistical decision theory to the treatment of advanced ovarian cancer. J Chron Dis 1985;38:171–186.
Simes JR: Publication bias: the case for an international registry of trials. J Clin Oncol 1986;4:1529–1541.
Simes RJ: Confronting publication bias: a cohort design for meta-analysis. Stat Med 1987;6:11–29.
Sisk JE, Riegelman RK: Cost effectiveness of vaccination against pneumococcal pneumonia: an update. Ann Intern Med 1986;104:79–86.
Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, Plouffe JF, Cetron MS, Butler JC: Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997;278:1333–1339.
Smith A: Qualms about QALYs. Lancet 1987;1:1134–1136.
Sonnenberg FA, Beck JR: Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322–338.
(p.293) Sox HC, Blatt MA, Higgins MC, Marton KI: Medical Decision Making. Stoneham, Mass, Butterworth, 1988.
Spilker B (ed): Quality of Life and Pharmacoeconomic Clinical Trials. Philadelphia, Pa, Lippincott-Raven, 1995.
Spitzer WO: State of science 1986: quality of life and functional status as target variables for research. J Chron Dis 1987;40:465–471.
Stampfer MJ, Goldhaber SZ, Yusuf S, Peto R, Hennekens CH: Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. N Engl J Med 1982;307:1180–1182.
Stampfer MJ, Colditz GA: Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47–63.
Steinberg KK, Thacker SB, Smith SJ, Stroup DF, Zack MM, Flanders WD, Berkelman RL. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991;265:1985–1990.
Sterling TD: Publication decisions and their possible effects on inferences drawn from tests of significance—or vice versa. JASA 1959;54:30–34.
Stock WA, Okun MA, Haring MJ, Miller W, Kinney C, Ceurvorst RW: Rigor in data synthesis: a case study of reliability in meta-analysis. Educ Res 1982;11:10–14, 20.
Stroup DF, Berlin JA, Morton S, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe T, Thacker SB: Meta-analysis of observational studies in epidemiology: summary of a workshop. Am J Epidemiol in press
Struewing JF, Watson R, Easton DF, Ponder RA, Lynch HT, Tucker MA: Prophylactic oophorectomy in inherited breast/ovarian cancer families. In: Hereditary Breast Cancer, Ovarian and Colon Cancer. NCI monographs. No. 17. Washington, D.C., Government Printing Office, 1995;33–35.
Sugden R, Williams A: The Principles of Practical Cost-Benefit Analysis. Oxford, Oxford University Press, 1990.
Tengs TO, Adama ME, Pliskin JS, Safran DG, Siegl JE, Weinstein MC, Graham JD: Five-hundred life-saving interventions and their cost-effectiveness. Risk Analysis 1995;15:369–390.
Thompson SG, Pocock SJ: Can meta-analysis be trusted? Lancet 1991;338:1127–1130.
Thompson SG: Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351–1355.
Tippett LHC: The Methods of Statistics. London, Williams and Norgate, 1931.
Torrance GW: Social preferences for health states: an empirical evaluation of three measurement techniques. Socio-Econ Plan Sci 1976;10:129–136.
Torrance GW: Preferences for health states: a review of measurement methods. Meade Johnson Symposium on Perinatal and Developmental Medicine 1982;20:37–45.
Torrance GW: Measurement of health state utilities for economic appraisal: a review. J Health Econ 1986;5:1–30.
Torrance GW: Utility approach to measuring health-related quality of life. J Chron Dis 1987;40:593–600.
Torrance GW, Boyle MH, Horwood SP: Application of multi-attribute utility theory to measure social preferences for health states. Oper Res 1982;30:1043–1069.
Torrance GW, Thomas WH, Sackett DL: A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118–133.
Tramer MR, Reynolds DJ, Moore RA, McQuay HJ: Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997;13:635–640.
Tversky A, Kahneman D: The framing of decisions and the psychology of choice. Science 1981;211:453–458.
(p.294) Ubel PA, DeKay ML, Baron J, Asch DA: Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996;334:1174–1177.
Udvarhelyi IS, Colditz GA, Rai A, Epstein AM: Cost-effectiveness and cost-benefit analyses in the medical literature: are the methods being used correctly? Ann Intern Med 1992;116:238–244.
United States Department of Health and Human Services: The Health Effects of Smoking Cessation. Public Health Service, Office on Smoking and Health. DHHS Publication No. (CDC) 90-8416, 1990; pp 449–453.
United States Environmental Protection Agency: Health Effects of Passive Smoking: Assessment of Lung Cancer in Adults and Respiratory Disorders in Children. US EPA Publication No. EPA-600-90-006A, Washington DC, 1990.
Van Agt HM, Essink-Bot ML, Krabbe PF, Bonsel GJ: Test-retest reliability of health state evaluations collected with the EuroQol questionnaire. Soc Sci Med 1994;39:1537–1544.
Villar J, Piaggio G, Carroli G, Donner A: Factors affecting the comparability of meta-analyses and largest trials results in perinatology. J Clin Epidemiol 1997;50:997–1002.
Villar J, Carroll G, Belizan JM: Predictive ability of meta-analyses of randomised controlled trials. Lancet 1995;345:772–776.
Von Neumann J, Morgenstern O: Theory of Games and Economic Theory. New York, Wiley, 1947.
Wachter KW: Disturbed by meta-analysis? Science 1988;241:1407–1408.
Walker AM, Martin-Moreno JM, Artalejo FR: Odd man out: a graphical approach to meta-analysis. Am J Public Health 1988;78:961–966.
Ware JE Jr, Snow KK, Kosinski M, et al: SF-36 Health Survey: Manual and Interpretation Guide. Boston, Mass, The Health Institute, New England Medical Center, 1993.
Ware JE, Sherbourne CD: The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473–183.
Ware JE Jr: Standards for validating health measures: definition and content. J Chron Dis 1987;40:473–480.
Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, DeWood MA, Ribichini F: Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093–2098.
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB: Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA 1996;276;1253–1258.
Weinstein MC, Stason WB: Cost-effectiveness of interventions to prevent or treat coronary heart disease. Ann Rev Public Health 1985;6:41–63.
Weinstein MC, Stason WB: Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med 1977;296:716–721.
Weinstein MC, Fineberg HV: Clinical Decision Analysis. Philadelphia, WB Saunders Company, 1980.
Welch GH, Larson EB: Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med 1989;321:807–812.
Whelton PK, He J, Cutler JA, Brancati FL, Appel LJ, Follmann D, Klag MJ: Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624–1632.
Williams A: Economics of coronary artery bypass grafting. Br Med J 1985;291:326–329.
Williamson DF, Parker RA, Kendrick JS: The box plot: a simple visual method to interpret data. Ann Intern Med 1989;110:916–921.
Winkelstein W: The first use of meta-analysis? Am J Epidemiol 1998;147:717.
Wolf FM: Meta-Analysis: Quantitative Methods for Research Synthesis. Newbury Park, Calif, Sage Publications, 1986.
(p.295) Wortman PM, Yeatman WH: Synthesis of results of controlled trials of coronary artery bypass graft surgery. In: Evaluation Studies. Review Annual, vol 8. Light R (ed). Beverly Hills, Calif, Sage Publications, 1983; pp 536–557.
Wright JC, Weinstein MC: Gains in life expectancy from medical interventions—standardizing data on outcomes. N Engl J Med 1998;339:380–386.
Yudkin PL, Ellison GW, Ghezzi A, Goodkin DE, Hughes RAC, McPherson K, Mertin J, Milanese C: Overview of azathioprine treatment in multiple sclerosis. Lancet 1991;338:1051–1055.
Yusuf S, Peto R, Lewis J, Collins R, Sleight P: Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335–371. (p.296)